For the first time in 15 years, employment across the major health insurance companies fell last year, according to a Modern Healthcare analysis.

With large opportunities in its target markets, management aims to continue growing at a fast pace with a long-term annual earnings per share growth goal of 11%-15%. While Humana appears focused ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...

The equity portion of the abrdn World Healthcare Fund fell (gross) but outperformed its custom benchmark over Q4 2024. Click ...

Humana’s shares (currently trading at $268.69) have posted a disappointing 15.2% loss while the S&P 500 was down 1.4%. This ...

FS KKR Capital's NAV declined significantly, and their dividend could be at risk if economic conditions worsen. Read why FSK ...

Humana’s (HUM) ongoing litigation with the Center for Medicaid & Medicaid Services on its Medicare Advantage Stars performance remains a ...

The analysis suggests that the ability to maintain consistent reserve strength is challenging, given the fluctuating performance metrics used in the ... In contrast, the analysts noted that Humana, ...